Babak Pezeshk is a Whittier, California based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He does not accept the Medicare-approved amount. Patients will be billed for the treatment. Active license number of Babak Pezeshk is 47547 for Oral and Maxillofacial Surgery in California. His current practice location is 6716 Greenleaf Ave, Whittier. Patients can reach him at 562-696-5544.
Babak Pezeshk deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Babak Pezeshk speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1760664692
NPI Enumeration Date:
03 Dec, 2007
NPI Last Update On:
29 Mar, 2019
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Babak Pezeshk are as mentioned below.
License Number
Specialization
State
Status
47547
Oral and Maxillofacial Surgery
California
Primary
47547
General Practice Dentistry
California
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
6716 Greenleaf Ave, Whittier, California
Zip:
90601-4109
Phone Number:
562-696-5544
Fax Number:
562-696-9221
Patients can reach Babak Pezeshk at 6716 Greenleaf Ave, Whittier, California or can call to book an appointment on 562-696-5544. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.